Toria / Shutterstock.com
On December 7, LSIPR will be hosting the Life Sciences Patents Network Europe 2016 at the Bloomsbury Hotel in London. Here we preview the main talking points.
Newton Media, the publisher of Life Sciences IP Review, is excited to host this publication’s first event. On December 7, 2016, the best and brightest people working in life sciences intellectual property, including in-house counsel and private practitioners, will converge on the Bloomsbury Hotel in London for a day of networking, education and debate.
So far, we have confirmed speakers from leading drugs companies Bayer, GSK, Novartis and Lundbeck, among others, and representatives from the European Patent Office and the European Commission will also be presenting.
We have attempted to cover as many important topics as possible in one day, but a couple stand out.
Life Sciences Intellectual Property Review (LSIPR) tracks the increasing challenges for intellectual property specialists in the rapidly evolving world of life sciences. From gene patents to stem cell research, we provide the very best news and analysis.
To continue reading this article and to access 4,500+ articles, our digital magazines and special reports published for LSIPR subscribers only then you will need a subscription.
If you are already subscribed please login.
Official LSIPR subscribers include:
Allen & Overy
Arnold & Siedsma
Birch, Stewart, Kolasch & Birch LLP (BSKB)
Carpmaels & Ransford
European Patent Office
George Washington Law School
Kirkland & Ellis International LLP
Marks & Clerk
NiKang Therapeutics Inc.
Powell Gilbert LLP
Procopio, Cory, Hargreaves & Savitch LLP
The United States Patent and Trademark Office (USPTO)
World Intellectual Property Office
Bayer, GSK, Novartis, Life Sciences Patents Network Europe 2016, supplementary protection certificates, generic, patent, life sciences,